Search

everythinglearnresearchcommunity

for

Search:↓

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Hairless gene not strongly linked to baldness.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

Ethosomes are a promising way to deliver drugs through the skin.

Zinc is essential for plant growth and human health, but many soils lack enough zinc, affecting crops and potentially leading to health problems.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

A gene called HDAC9 might be a new factor in male-pattern baldness.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Tamoxifen caused hair loss in a 52-year-old woman.